NEUCA S.A. (WSE:NEU)

Market Cap	3.38B -7.8%
Revenue (ttm)	13.34B +8.1%
Net Income	153.80M -4.7%
EPS	33.88 -4.8%
Shares Out	4.50M
PE Ratio	22.14
Forward PE	18.36
Dividend	16.00 (2.13%)
Ex-Dividend Date	Jul 15, 2025

Volume	626
Average Volume	913
Open	752.00
Previous Close	750.00
Day's Range	743.00 - 769.00
52-Week Range	636.00 - 857.00
Beta	0.37
RSI	41.61
Earnings Date	Mar 26, 2026

About NEUCA

NEUCA S.A. engages in the wholesale distribution of pharmaceuticals in Poland. It operates through Wholesale Distribution of Medicines, Manufacture of Pharmaceuticals, Medical Operator, Clinical Trials, and Insurance Activities segments. The company offers Rx, OTC drugs, dietary supplements, medical devices, dermocosmetics, hygiene products, personal protective equipment, as well as diagnostic and dressing materials under the Świat Zdrowia, APTEO, GENOPTIM, CERA+ Solutions, and Kic Kic brands. It also provides medical care services, including p...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1990
• Employees: 4,445
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: NEU

Financial Performance

In 2024, NEUCA's revenue was 12.61 billion, an increase of 6.76% compared to the previous year's 11.81 billion. Earnings were 154.24 million, an increase of 5.45%.